Human Death Receptor 4 (DR4) antibodies are provided. The human DR4 antibodies may be included in pharmaceutical compositions, articles of manufacture, or kits. Methods of treatment and diagnosis using the DR4 antibodies are also provided.
申请公布号
WO03066661(A3)
申请公布日期
2003.11.27
申请号
WO2002US20712
申请日期
2002.06.29
申请人
GENENTECH, INC.;CHUNTHARAPAI, ANAN;KIM, KYUNG, JIN